Support PenkeIonis Pharmaceuticals Inc - Trending symbols
Latest News of Ionis Pharmaceuticals Inc
| Date | Title | Read |
|---|---|---|
| 2025-08-22 15:15 | Sector Update: Health Care Stocks Rise Pre-Bell Friday | Read |
| 2025-08-21 21:17 | Ionis Pharmaceuticals stock price target raised to $43 by Stifel on Dawnzera approval | Read |
| 2025-08-21 19:40 | US FDA approves Ionis' drug for rare genetic disorder | Read |
| 2025-08-21 19:39 | Ionis Pharmaceuticals stock steady as BMO maintains Market Perform rating | Read |
| 2025-07-31 15:10 | Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook | Read |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Income before Tax | -66,201 | -77,900 | -144,101 | 37,062 | -107,039 | -39,783 | -146,822 | 270,822 | 124,000 | |
| Net Income | -66,265 | -74,215 | -140,480 | 36,131 | -104,349 | -42,589 | -146,938 | 270,938 | 124,000 | |
| EBITDA | -37,836 | -78,078 | -115,914 | 37,041 | -78,873 | -65,018 | -143,891 | 283,891 | 140,000 | |
| Operating Income | -66,091 | -82,565 | -148,656 | 37,833 | -110,823 | -36,037 | -146,860 | 286,860 | 140,000 | |
| Net Income from Continuing Operations | -66,265 | -74,215 | -140,480 | 36,131 | -104,349 | -42,589 | -146,938 | 270,489 | 123,551 | |
| Net Debt | 1,682,996 | -570,947 | 1,112,049 | 62,443 | 1,174,492 | -28,574 | 1,145,918 | -2,581,918 | -1,436,000 | |
| Tax Provision | 6,000 | 496 | 6,496 | -6,421 | 75 | -11 | 64 | -3,685 | -3,621 | |
| Income Tax Expense | 6,000 | 496 | 6,496 | -6,421 | 75 | -11 | 64 | -4,064 | -4,000 | |
| Total Other Income Expense Net | 32,000 | -12,000 | 20,000 | 5,763 | 25,763 | -18,978 | 6,785 | -6,895 | -110 | |
| Gross Profit | 137,749 | -8,703 | 129,046 | 29,206 | 158,252 | -10,252 | 148,000 | -179,856 | -31,856 | |
| Depreciation and Amortization | 4,984 | -89 | 4,895 | 191 | 5,086 | -5,064 | 22 | -10,236 | -10,214 | |
| Other Current Assets | 136,643 | 6,731 | 143,374 | 7,203 | 150,577 | -7,818 | 142,759 | -1,830,074 | -1,687,315 | |
| Other Current Liabilities | 111,110 | 16,260 | 127,370 | -7,383 | 119,987 | 44,066 | 164,053 | -189,584 | -25,531 | |
| Other Stockholders Equity | 1,910,379 | 31,969 | 1,942,348 | 21,819 | 1,964,167 | 18,911 | 1,983,078 | -2,037,085 | -54,007 | |
| EBIT | -10,984 | -77,255 | -88,239 | 10,048 | -78,191 | -3,242 | -81,433 | 303,538 | 222,105 | |
| Interest Expense | 11,506 | -10,006 | 1,500 | 857 | 2,357 | -17 | 2,340 | -5,151 | -2,811 | |
| Net Income Applicable to Common Shares | -340,271 | 250,402 | -89,869 | 8,994 | -80,875 | -1,591 | -82,466 | 307,079 | 224,613 |
Comments
How you think about this?